Jasper Therapeutics, Inc. (JSPR)

NASDAQ

$16.06

$+0.23

(+1.66%)

Regular Market

Jasper Therapeutics, Inc. (JSPR) Live Price Chart

Last updated: ⁦2026-11-06 17:58:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Jasper Therapeutics, Inc. (JSPR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $16.06, with a market capitalization of $17.01M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.27 to $72.60. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$17.01M
Open	$12.76
Day's High	$5,664.00
Day's Low	$2.27
Previous Close	$14.08
Volume	50.76K
Average Volume	16.41K
P/E Ratio	--
52-Week High	$72.60
52-Week Low	$2.27
Dividend Yield	--
Earnings Date	--

Jasper Therapeutics, Inc. (JSPR) Stock Price Today

Jasper Therapeutics, Inc. (JSPR) is currently trading at $16.06 as of 2026-11-06 17:57:00, up 14.08% ($1.98) from the previous close of $14.08

During today's regular trading session, JSPR has traded between $2.27 and $5,664.00, with a trading volume of 50.76K shares. The current price is near the lower end of today's range.

Jasper Therapeutics, Inc. (JSPR) 7-Day Stock Price Change

Over the past seven days, Jasper Therapeutics, Inc. (JSPR) moved from $16.16 to $16.06, representing a decline of 0.66% ($0.11).

The stock traded between $2.27 and $16.90 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.

The average daily volume was 15.31 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

JSPR 52-Week Price Position

Position in Range: 19.6%

52W Low$2.27

52W High$72.60

JSPR is currently trading at $16.06, placing it 19.6% of the way from its 52-week low of $2.27 to its 52-week high of $72.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Jasper Therapeutics, Inc. (JSPR)?

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Jasper Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	22
Exchange	NASDAQ
Company Website	https://www.jaspertherapeutics.com

How to Buy Jasper Therapeutics, Inc. (JSPR) Stock on MEXC

Eligible investors can buy real shares of Jasper Therapeutics, Inc. (JSPR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for JSPR and Place Your Order

Open the RealStocks trading page and search for JSPR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Jasper Therapeutics, Inc. (JSPR) stock price today?

Jasper Therapeutics, Inc. (JSPR) is currently trading at $ 16.06, up 14.08% ($1.98) from the previous close of $ 14.08. Intraday prices update in real time during regular trading hours.

2.Is JSPR stock going up or down today?

As of 2026-11-06 17:57:00, JSPR is trading at $ 16.06, up 14.08% ($1.98) from its previous close of $ 14.08. The stock has traded between $ 2.27 and $ 5,664.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is JSPR pre-market price?

As of 2026-11-06 17:57:00, JSPR is trading at $ 0.50 in pre-market trading, down 96.48% ($13.58) from the previous close of $ 14.08. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is JSPR after-hours price?

As of 2026-11-06 17:57:00, JSPR is trading at $ 0.48 in after-hours trading, down 96.63% ($13.60) from the regular-session close of $ 14.08. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is JSPR stock trading now?

JSPR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does JSPR sit relative to its 52-week high and low?

Over the past 52 weeks, JSPR has traded between a low of $ 2.27 and a high of $ 72.60. At $ 16.06, the stock is positioned 19.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Jasper Therapeutics, Inc. in?

Jasper Therapeutics, Inc. (JSPR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Jasper Therapeutics, Inc.'s market capitalization and where is it listed?

Jasper Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 17.01M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is JSPR valued in terms of P/E ratio and EPS?

JSPR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.95. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Jasper Therapeutics, Inc. pay a dividend?

Jasper Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.